PAPERS - RESEARCH FRONT: 2
| TITLE | 1ST AUTHOR | YEAR |
| FROM SLOW VIRUS TO PRION - A REVIEW OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES |
LANTOS PL |
1992 |
| RECENTLY DESCRIBED SCRAPIE-LIKE ENCEPHALOPATHIES OF ANIMALS - CASE DEFINITIONS |
WELLS GAH |
1992 |
| IMMUNOREACTIVITY TO UBIQUITIN PROTEIN CONJUGATES IS PRESENT EARLY IN THE DISEASE PROCESS IN THE BRAINS OF SCRAPIE-INFECTED MICE |
LOWE J |
1992 |
| PRION PROTEIN IMMUNOCYTOCHEMISTRY HELPS TO ESTABLISH THE TRUE INCIDENCE OF PRION DISEASES |
LANTOS PL |
1992 |
| SYNAPTIC DEGENERATION IS THE PRIMARY NEUROPATHOLOGICAL FEATURE IN PRION DISEASE - A PRELIMINARY-STUDY |
CLINTON J |
1993 |
| GENETIC-CHARACTERIZATION OF A FAMILIAL NONSPECIFIC DEMENTIA ORIGINATING IN JUTLAND, DENMARK |
BROWN J |
1993 |
| CREUTZFELDT-JAKOB DISEASE - REPORT OF A CASE OF THE PANENCEPHALOPATHIC TYPE AND EXPERIENCES OF A TEACHING HOSPITAL IN TAIWAN |
SU MS |
1993 |
| ABSENCE OF PROTEASE-RESISTANT PRION PROTEIN IN DEMENTIA CHARACTERIZED BY NEURONAL LOSS AND STATUS SPONGIOSUS |
POLLANEN MS |
1993 |
| EXPRESSION OF POLYUBIQUITIN AND HEAT-SHOCK PROTEIN-70 GENES INCREASES IN THE LATER STAGES OF DISEASE PROGRESSION IN SCRAPIE-INFECTED MOUSE-BRAIN |
KENWARD N |
1994 |
| CHROMOSOME 14-ENCODED ALZHEIMERS-DISEASE - GENETIC AND CLINICOPATHOLOGICAL DESCRIPTION |
HALTIA M |
1994 |
| VERTICAL TRANSMISSION OF PRION DISEASE |
BROWN P |
1994 |
| VERTICAL TRANSFER OF PRION DISEASE - REPLY |
WILL RG |
1994 |
| THE NEUROPATHOLOGY AND EPIDEMIOLOGY OF BOVINE SPONGIFORM ENCEPHALOPATHY |
WELLS GAH |
1995 |
| ALLELIC VARIATIONS IN APOLIPOPROTEIN-E AND PRION PROTEIN GENOTYPE RELATED TO PLAQUE-FORMATION AND AGE-OF-ONSET IN SPORADIC CREUTZFELDT-JAKOB-DISEASE |
PICKERINGBROWN SM |
1995 |
| LIMITATIONS OF DOT-BLOT IMMUNOASSAY IN THE DIAGNOSIS OF CREUTZFELDT-JAKOB-DISEASE |
JEZIORE Y |
1995 |
| SPASTIC TETRAPLEGIA AS AN INITIAL MANIFESTATION OF FAMILIAL ALZHEIMERS-DISEASE |
SODEYAMA N |
1995 |
| Precocious loss of physiological sleep in a case of Creutzfeldt-Jakob disease: A serial polygraphic study |
Terzano MG |
1995 |
| Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: A retrospective archival survey with implications for future research |
Bruton CJ |
1995 |
| Cellular prion protein and GABA(A) receptors: No physical association? |
Kannenberg K |
1995 |
| Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer's disease |
Fox N |
1996 |
| Neurogenetics |
Reichmann H |
1996 |
| A panencephalopathic type of Creutzfeldt-Jakob disease with selective lesions of the thalamic nuclei in 2 Swiss patients |
Carota A |
1996 |
| Hippocampal slices from prion protein null mice: Disrupted Ca2+-activated K+ currents |
Colling SB |
1996 |
| Creutzfeldt-Jakob disease in Austria |
Hainfellner JA |
1996 |
| Two cases of frontal dementia with non specific histological lesions: Nosology clinicopathological discussion |
Michel B |
1996 |
| Mechanochemical mechanism for peptidyl free radical generation by amyloid fibrils |
Kay CJ |
1997 |
| The nature of transmission in prion diseases |
Ridley RM |
1997 |
| Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease |
Diez M |
1997 |
| Conformational change in prion protein: Testing a novel method of secondary structure prediction |
Yan JF |
1998 |
| MRI in sporadic Creutzfeldt-Jakob disease: Correlation with clinical and neuropathological data |
Urbach H |
1998 |
| Characterization of the sheep apolipoprotein E (ApoE) gene and allelic variations of the ApoE gene in scrapie Suffolk sheep |
Komatsu Y |
1998 |
| Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system |
Hokfelt T |
1998 |
| Neuro-ophthalmological aspects of prion diseases |
Neetens A |
1998 |
| Differential expression of transforming growth factor-beta isoforms in human prion diseases |
Tashiro H |
1998 |
| Protein precipitation: a common etiology in neurodegenerative disorders? |
Kakizuka A |
1998 |
| Phenotypic variability in fatal familial insomnia (D178N-129M) genotype |
Zerr I |
1998 |
| Genetic classification of primary neurodegenerative disease |
Hardy J |
1998 |
| Conformation and neurotoxicity: relationship between Alzheimer's disease and prion disease |
Kawahara M |
1998 |
| The genetics of disorders with synuclein pathology and parkinsonism |
Farrer M |
1999 |
| Risk of prion disease transmission from ocular donor tissue transplantation |
Hogan RN |
1999 |
| Possible retroviral origin of prion disease: could prion disease be reconsidered as a preleukemia syndrome? |
Labat ML |
1999 |
| Neuropathological study of cerebellar degeneration in prion disease |
Yang Q |
1999 |
| Prion infections in Creutzfeldt-Jakob disease and its variants |
Parker JC |
1999 |
| Early induction of protein nexin-I in scrapie |
Cavallaro S |
1999 |
| The role of copper in neurodegenerative disease |
Waggoner DJ |
1999 |
| Intrinsic physiological and morphological properties of principal cells of the hippocampus and neocortex in hamsters infected with scrapie |
Barrow PA |
1999 |
| How to improve the clinical diagnosis of Creutzfeldt-Jakob disease |
Poser S |
1999 |
| Novel PRNP sequence variant associated with familial encephalopathy |
Cervenakova L |
1999 |
| Pathways to primary neurodegenerative disease |
Hardy J |
2000 |
| High frequency of mutations in four different disease genes in early-onset dementia |
Finckh U |
2000 |
| The diagnosis of human prion diseases |
Kordek R |
2000 |
| High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes |
Finckh U |
2000 |
| Amyotrophy in prion diseases |
Worrall BB |
2000 |
| Familial Creutzfeldt-Jakob disease: A neuropsychological case study |
Gass CS |
2000 |
| Major hypercorticism is an endocrine feature of ewes with naturally occurring scrapie |
Gayrard V |
2000 |
| Heat shock modulates prion protein expression in human NT-2 cells |
Shyu WC |
2000 |
| Naturally occurring scrapie is associated with a lower CBG binding capacity in ewes |
Picard-Hagen N |
2000 |
| Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease |
Collins S |
2000 |
| Amyloid in the central nervous system |
Ortega-Aznar A |
2000 |
| Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides |
Baumann MH |
2000 |
| Inherited prion encephalopathy associated with the novel PRNP H187R mutation - A clinical study |
Butefisch CM |
2000 |
| Copper-dependent oxidative stress and neurodegeneration |
Rotilio G |
2000 |
| Neuronal apoptosis as a therapeutic target in neurodegenerative disease |
Larner AJ |
2000 |
| Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: Channel formation and disruption of calcium homeostasis |
Kawahara M |
2000 |
| Creutzfeldt-Jakob disease: heat shock protein 70 mRNA levels in mononuclear blood cells and clinical study |
Shyu WC |
2000 |
| Genetic dissection of neurodegenerative disease |
Hardy J |
2001 |
| Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease |
Armstrong RA |
2001 |
| Serotonergic nuclei of the raphe are not affected in human ageing |
Kloppel S |
2001 |
| Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease |
Lecerf JM |
2001 |
| Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family |
Kovacs GG |
2001 |
| The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia |
Saiz A |
2001 |
| A new PRNP mutation (G131V) associated with Gerstmann-Straussler-Scheinker disease |
Panegyres PK |
2001 |
| Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels |
Liguori R |
2001 |
| Immunohistochemistry for the prion protein: Comparison of different monoclonal antibodies in human prion disease subtypes |
Kovacs GG |
2002 |
| Disordered proteins in dementia |
Ingelsson M |
2002 |
| beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia |
Kloppel S |
2002 |
| A marked disparity between the expression of prion protein and its message by neurones of the CNS |
Ford MJ |
2002 |
| Prion diseases. An overview |
Dalsgaard NJ |
2002 |
| Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death |
Larner AJ |
2002 |
| Multiplicative genetic effects in scrapie disease susceptibility |
Dubois MA |
2002 |
| Creutzfeldt-Jakob disease. Lack of correlation between cerebral cortical histology and clinical course of the disease in 22 autopsy cases |
Geiger KD |
2002 |
| Sporadic and familial cerebral amyloid angiopathies |
Revesz T |
2002 |
| Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases |
Kovacs GG |
2002 |
| Amyloidogenic unfolding intermediates differentiate sheep prion protein variants |
Rezaei H |
2002 |
| The expanding role of imaging in prion disease |
Taber KH |
2002 |
| Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and, analogues: Implications for the design of fibrillization inhibitors |
Gazit E |
2002 |
| Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide |
Mazor Y |
2002 |
| Folding pathways of prion and doppel |
Settanni G |
2002 |
| Diffusion-weighted sequence on MRI for the diagnosis of Creutzfeldt-Jakob disease |
Pereira E |
2002 |
| Basic and clinical aspects of copper |
Harris ED |
2003 |
| Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease |
Jarius C |
2003 |
| Bovine spongiform encephalopathy in Israel: Implications for human health |
Nitzan-Kaluski D |
2003 |
| Gerstmann-Straussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset |
Bianca M |
2003 |
| Aluminum-induced conformational changes of beta-amyloid protein and the pathogenesis of Alzheimer's disease |
Kawahara M |
2003 |
| Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo |
Boche D |
2003 |
| Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease |
Depino AM |
2003 |
| Cerebrospinal fluid tau and beta-amyloid - How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? |
Clark CM |
2003 |
| Current concepts and future prospects for Alzheimer disease vaccines |
Heppner FL |
2004 |
| Biomarkers in non-Alzheimer dementias |
Galasko D |
2004 |
| Quantitative study of spongiform change in putamen of 24 cases of Creutzfeldt-Jakob disease |
Truchot L |
2004 |
| The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease |
Perry VH |
2004 |
| Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases |
Chretien F |
2004 |
| Loss of glycosylation associated with the T183A mutation in human prion disease |
Grasbon-Frodl E |
2004 |
| Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain |
Galea I |
2005 |
| Polygenic variation and transmission factors involved in the resistance/susceptibility to scrapie in a Romanov flock |
Diaz C |
2005 |
| Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro |
Tahiri-Alaoui A |
2005 |
| Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene |
Tsuboi Y |
2005 |
| Asymmetric cortical high signal on diffusion weighted-MRI in a case of Creutzfeldt-Jakob disease |
Nitrini R |
2005 |
| Role of inflammation in neurodegenerative diseases |
Minghetti L |
2005 |
| Overlap between neurodegenerative disorders |
Armstrong RA |
2005 |